| scholarly article | Q13442814 |
| P2093 | author name string | Caroline L Bodinham | |
| Leanne Smith | |||
| M Denise Robertson | |||
| Najlaa M Al-Mana | |||
| P2860 | cites work | Dietary fibre improves first-phase insulin secretion in overweight individuals | Q21560785 |
| Resistant starch from high-amylose maize increases insulin sensitivity in overweight and obese men | Q24617779 | ||
| Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2 | Q28592795 | ||
| Resistant starch improves insulin sensitivity in metabolic syndrome. | Q34120053 | ||
| The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal | Q34175668 | ||
| Prior short-term consumption of resistant starch enhances postprandial insulin sensitivity in healthy subjects | Q34192590 | ||
| The role of incretins in glucose homeostasis and diabetes treatment | Q34901533 | ||
| Acute ingestion of resistant starch reduces food intake in healthy adults | Q35009545 | ||
| Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents | Q36976985 | ||
| Dietary resistant starch increases hypothalamic POMC expression in rats | Q37317358 | ||
| Dietary-resistant starch and glucose metabolism | Q38003278 | ||
| The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects | Q43174417 | ||
| Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects | Q43296243 | ||
| Effect of the glycemic index and content of indigestible carbohydrates of cereal-based breakfast meals on glucose tolerance at lunch in healthy subjects | Q43605089 | ||
| Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects | Q46603061 | ||
| GLP-1 (9-36) amide, cleavage product of GLP-1 (7-36) amide, is a glucoregulatory peptide | Q46637836 | ||
| The glucagon-like peptide-1 metabolite GLP-1-(9-36) amide reduces postprandial glycemia independently of gastric emptying and insulin secretion in humans | Q46887678 | ||
| Including indigestible carbohydrates in the evening meal of healthy subjects improves glucose tolerance, lowers inflammatory markers, and increases satiety after a subsequent standardized breakfast. | Q47828209 | ||
| Greater satiety response with resistant starch and corn bran in human subjects | Q48292511 | ||
| Effects of resistant starch, a non-digestible fermentable fiber, on reducing body fat. | Q51719966 | ||
| Resistant starch: the effect on postprandial glycemia, hormonal response, and satiety. | Q54193229 | ||
| Peptide YY and proglucagon mRNA expression patterns and regulation in the gut. | Q54598722 | ||
| The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity | Q58448710 | ||
| Sugar and dietary fibre composition influence, by different hormonal response, the satiating capacity of a fruit-based and a β-glucan-enriched beverage | Q63410040 | ||
| The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction | Q74287135 | ||
| P433 | issue | 8 | |
| P304 | page(s) | 1429-1433 | |
| P577 | publication date | 2013-03-18 | |
| P1433 | published in | British Journal of Nutrition | Q4970206 |
| P1476 | title | Endogenous plasma glucagon-like peptide-1 following acute dietary fibre consumption | |
| P478 | volume | 110 |
| Q41195107 | Acute Consumption of Resistant Starch Reduces Food Intake but Has No Effect on Appetite Ratings in Healthy Subjects. |
| Q60953826 | Acute Effect of Resistant Starch on Food Intake, Appetite and Satiety in Overweight/Obese Males |
| Q50334394 | Acute increases in serum colonic short-chain fatty acids elicited by inulin do not increase GLP-1 or PYY responses but may reduce ghrelin in lean and overweight humans |
| Q41491222 | An enriched, cereal-based bread affects appetite ratings and glycemic, insulinemic, and gastrointestinal hormone responses in healthy adults in a randomized, controlled trial. |
| Q92169716 | An introductory review of resistant starch type 2 from high-amylose cereal grains and its effect on glucose and insulin homeostasis |
| Q38250323 | Contributions of colonic short-chain Fatty Acid receptors in energy homeostasis |
| Q91963511 | Effect of Fibre-Enriched Orange Juice on Postprandial Glycaemic Response and Satiety in Healthy Individuals: An Acute, Randomised, Placebo-Controlled, Double-Blind, Crossover Study |
| Q37703734 | Efficacy of increased resistant starch consumption in human type 2 diabetes. |
| Q34120699 | Evidence for the gut microbiota short-chain fatty acids as key pathophysiological molecules improving diabetes |
| Q90568510 | Fasting Glucose State Determines Metabolic Response to Supplementation with Insoluble Cereal Fibre: A Secondary Analysis of the Optimal Fibre Trial (OptiFiT) |
| Q55919832 | Health effects of resistant starch |
| Q36509951 | Improving Effect of the Acute Administration of Dietary Fiber-Enriched Cereals on Blood Glucose Levels and Gut Hormone Secretion |
| Q52679538 | Male grower pigs fed cereal soluble dietary fibres display biphasic glucose response and delayed glycaemic response after an oral glucose tolerance test. |
| Q64072898 | Metabolic phenotypes and the gut microbiota in response to dietary resistant starch type 2 in normal-weight subjects: a randomized crossover trial |
| Q91882025 | Perspective: Physiologic Importance of Short-Chain Fatty Acids from Nondigestible Carbohydrate Fermentation |
| Q38364477 | Possible abilities of dietary factors to prevent and treat diabetes via the stimulation of glucagon-like peptide-1 secretion |
| Q99414119 | Potato Preload Mitigated Postprandial Glycemic Excursion in Healthy Subjects: An Acute Randomized Trial |
| Q37628014 | Resistant starch can improve insulin sensitivity independently of the gut microbiota |
| Q35910146 | Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients? |
| Q28267803 | Resistant starches for the management of metabolic diseases |
| Q58447614 | Specificity and sensitivity of commercially available assays for glucagon-like peptide-1 (GLP-1): implications for GLP-1 measurements in clinical studies |
| Q42323036 | The acute effects of inulin and resistant starch on postprandial serum short-chain fatty acids and second-meal glycemic response in lean and overweight humans |
Search more.